A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples